MODIFIZIERTE ANTI-CD4-ANTIKÖRPER

European patent · EP3351255 · In force

Register entry

Publication number
EP3351255
Application number
EP18159086
Kind
European patent with effect for Switzerland and Liechtenstein
Status
In force
Specification
Granted
Filed
Dec 2, 2011
Published
Jul 25, 2018
Granted
Aug 26, 2020
Protection ends at the latest
Dec 1, 2031
Next annual fee due
Dec 31, 2026
IPC classes
A61K 39/395 (2006.01)
A61K 35/28 (2015.01)
C12N 5/00 (2006.01)
C07K 16/28 (2006.01)
A61P 37/06 (2006.01)
Priority
EP 10015236 02.12.2010
Filing language
English
Source
Swissreg

History

What the Federal Institute of Intellectual Property published about this title, newest first.

  1. Jan 1, 2026

    Change

    Published in Swissreg on 01.01.2026

  2. Jan 1, 2025

    Change

    Published in Swissreg on 01.01.2025

  3. Jan 9, 2024

    Change

    Published in Swissreg on 09.01.2024

  4. May 9, 2023

    Address changed

    Representative
    Valipat S.A., c/o BOVARD SA Neuchâtel, Rue des Noyers 11, 2000 Neuchâtel → VALIPAT, c/o BOVARD LTD, Optingenstrasse 16, 3013 Bern

    Published in Swissreg on 09.05.2023

  5. Jan 4, 2023

    Change

    Published in Swissreg on 04.01.2023

  6. Oct 8, 2020

    Agent entered

    Representative
    Valipat S.A., c/o BOVARD SA Neuchâtel, Rue des Noyers 11, 2000 Neuchâtel

    Published in Swissreg on 08.10.2020

  7. Aug 26, 2020

    Granted

    Published in Swissreg on 26.08.2020

Parties

Holder

Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V.

Hansastrasse 27c, 80686 München, DE

Agent

VALIPAT

c/o BOVARD LTD Optingenstrasse 16, 3013 Bern

Inventor

EMMRICH, Frank

04299 Leipzig, DE

FRICKE, Stephan

04229 Leipzig, DE

HILGER, Nadja

04107 Leipzig, DE

The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.